PAVmed (PAVM) Total Current Liabilities (2015 - 2025)

PAVmed's Total Current Liabilities history runs 11 years deep, the most recent figure standing at $14.8 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 58.14% year-over-year to $14.8 million in Q4 2025; TTM through Dec 2025 was $14.8 million, a 58.14% decrease from a year earlier, with the FY2025 full-year figure at $14.8 million, down 58.14% from the prior year.
• Total Current Liabilities improved to $14.8 million in Q4 2025 per PAVM's latest filing, from $10.5 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $55.0 million in Q1 2024 and bottomed at $7.6 million in Q4 2021.
• The 5-year median for Total Current Liabilities is $38.9 million (2022), against an average of $33.0 million.
• Across the five-year window, Total Current Liabilities jumped 445.12% in 2022 and slumped 82.22% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $7.6 million in 2021, then soared by 445.12% to $41.2 million in 2022, then surged by 31.5% to $54.2 million in 2023, then sank by 34.57% to $35.4 million in 2024, then plunged by 58.14% to $14.8 million in 2025.
• Per Business Quant, the three latest PAVM Total Current Liabilities figures stand at $14.8 million (Q4 2025), $10.5 million (Q3 2025), and $10.5 million (Q2 2025).